SCHEMBL396973

SCHEMBL396973

CC1CCN(c2cc(C(=O)Nc3cccc(Nc4ccc5c(c4)NC(=O)/C5=C\c4cc(C#N)c[nH]4)c3)cc(C(F)(F)F)c2)CC1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK2 Q16620 9/20 0.86
▸ NTRK1 P04629 14/20 0.72
▸ SRC P12931 2/20 0.58
▸ AURKA O14965 1/20 0.58
▸ RAF1 P04049 1/20 0.58
▸ NTRK3 Q16288 5/20 0.56
▸ AURKB Q96GD4 1/20 0.44
▸ TLK2 Q86UE8 1/20 0.41
▸ JAK2 O60674 1/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ INSR P06213 1/20 0.40
▸ CSF1R P07333 1/20 0.40
▸ LYN P07948 1/20 0.40
▸ RET P07949 1/20 0.40
▸ IGF1R P08069 1/20 0.40
▸ MET P08581 1/20 0.40
▸ ROS1 P08922 1/20 0.40
▸ PDGFRB P09619 1/20 0.40
▸ FGR P09769 1/20 0.40
▸ KIT P10721 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL396974 1.00 NTRK2 (0.86) NTRK2NTRK1SRCAURKARAF1
SCHEMBL398639 0.95 NTRK2 (0.86) NTRK2NTRK1SRCAURKARAF1
SCHEMBL398638 0.95 NTRK2 (0.86) NTRK2NTRK1SRCAURKARAF1
SCHEMBL398254 0.92 NTRK2 (1.00) NTRK2NTRK1SRCAURKARAF1
SCHEMBL398255 0.92 NTRK2 (1.00) NTRK2NTRK1SRCAURKARAF1
SCHEMBL10091988 0.87 NTRK2 (0.75) NTRK2NTRK1SRCAURKARAF1
SCHEMBL397883 0.85 NTRK1 (0.80) NTRK2NTRK1SRCAURKARAF1
SCHEMBL397882 0.85 NTRK1 (0.80) NTRK2NTRK1SRCAURKARAF1
SCHEMBL396447 0.85 NTRK2 (0.85) NTRK2NTRK1SRCAURKARAF1
SCHEMBL396446 0.85 NTRK2 (0.85) NTRK2NTRK1SRCAURKARAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101608-B2 3-(4-Methyl-imidazol-1-yl)-N-{3-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indol-6-ylamino]-phenyl}-5-trifluoromethyl-benzamide; including benign and malignant proliferative disorders as well as diseases resulting from inappropriate activation of the immune and nervous systems IRM LLC, a Delware Limited Corporation (BM) 2012-01-24 — — US claimed
Send feedback